Unwanted side effects of NSAIDs and of COX-2 inhibitors, the latter of which have recently received considerable attention (Fitzgerald, 2004), may ultimately militate against their extensive use as cancer chemopreventive agents in humans. This evidence concerns the gene PTGS2 and cancer.